Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 11 of 849 for:    Advanced | Neuroendocrine Tumors

RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00576680
Recruitment Status : Active, not recruiting
First Posted : December 19, 2007
Last Update Posted : July 24, 2019
Sponsor:
Collaborators:
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Massachusetts General Hospital
Novartis
Schering-Plough
Information provided by (Responsible Party):
Jennifer Chan, MD, MPH, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 2019
Estimated Study Completion Date : December 2019